Abbott Laboratories

Abbott Laboratories
Company type	Public
Traded as	NYSE: ABT; S&P 100 component; S&P 500 component;
Industry	Health care; Medical devices; Pharmaceutical;
Founded	1888 (as Abbott Alkaloidal Company) in Ravenswood, Chicago
Founder	Wallace Calvin Abbott
Successor	AbbVie
Headquarters	Abbott Park, Illinois, U.S.
Area served	Worldwide
Key people	Robert B. Ford; (chairman & CEO); Robert Funck; (EVP & CFO);
Products	Pharmaceutical drugs; Generic drugs; Medical devices; Diagnostic assays; Dietary supplements; Nutritionals;
Revenue	US$44.3 billion (2025)
Operating income	US$8.05 billion (2025)
Net income	US$6.52 billion (2025)
Total assets	US$86.7 billion (2025)
Total equity	US$52.1 billion (2025)
Number of employees	c. 115,000 (2025)
Website	abbott.com
	Footnotes / references;

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States (13% of 2024 revenues), diagnostic products (20% of 2024 revenues), nutritional products (22% of 2024 revenues), and medical devices (45% of 2024 revenues).

Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide.

Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.

The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000.